有机药用辅料市场－全球产业规模、份额、趋势、机会及预测（按类型、功能、应用、地区和竞争格局划分，2021-2031年）

全球有机药用辅料市场预计将从 2025 年的 105.6 亿美元成长到 2031 年的 168.6 亿美元，复合年增长率达到 8.11%。

有机药用辅料是指源自经认证的天然来源的非活性成分，例如植物来源淀粉、树胶和纤维素，它们在保持无化学成分特性的同时，被用于药物製剂中。推动这一市场发展的主要因素是消费行为的根本性转变，即更加重视预防性医疗保健以及对产品透明度的强烈需求，促使製造商用天然成分取代合成化学物质。近期行业数据也印证了这个趋势。根据有机贸易协会 (OTA) 的报告，到 2024 年，美国有机非食品产品的销售额将达到 62 亿美元，这表明消费者对有机个人护理和医疗保健解决方案有着巨大的经济投入，而这直接影响着药品采购决策。

然而，维持稳定的有机供应链高成本且面临许多复杂挑战，阻碍了市场成长。世界各地对有机认证的严格要求导致原材料频繁短缺和价格波动。这种符合标准的药用级原料短缺，使得生产商无法扩大生产规模，最终延缓了新型有机药物製剂的商业性化上市。

市场驱动因素

蓬勃发展的膳食补充剂和保健品产业是推动有机药用辅料使用的主要动力。随着人们对预防保健的日益关注，消费者显然更倾向于选择使用经认证的有机替代品（例如植物来源纤维素）製成的「洁净标示」产品，而不是合成填充剂和粘合剂。这种转变迫使製造商寻找与活性成分天然特性相符的原料，以维持产品标准并符合认证要求。近期的数据凸显了消费者对这种需求的强度。根据责任营养委员会 (CRN) 于 2024 年 10 月发布的《2024 年膳食补充剂消费者调查》，75% 的美国人使用膳食补充剂，凸显了有机输送系统的巨大市场潜力。

同时，慢性病发病率的上升推动了整体药品消费量的成长，从而对生物相容性辅料产生了持续的需求。对于糖尿病和肿瘤等高负担疾病，使用能够确保患者安全并最大限度降低长期毒性的辅料製定长期治疗方案至关重要。根据美国癌症协会于2024年1月发布的《2024年癌症事实与数据》，美国新增癌症病例数预计将首次超过200万例，凸显了扩大药品生产的迫切需求。目前，药品生产主要依赖专利到期药物，而有机淀粉因其功能稳定性和成本效益，其使用量正在增加。正如可及药品协会在2024年指出的那样，学名药占美国所有处方笺的90%，这使其成为有机辅料应用的主要量主导途径。

市场挑战

高昂的营运成本和维护稳定有机供应链的复杂性，对全球有机药用辅料市场的成长构成了重大障碍。与传统原料不同，有机胶和淀粉必须遵守严格的监管标准，而这些标准在国际上差异很大。认证系统的碎片化造成了物流延误，并限制了符合标准的药用级原料的供应。因此，製造商难以实现高效生产所需的规模经济，导致价格不稳定，并阻碍了製药公司转型为有机配方。

天然成分需求的不断增长与全球用于有机农业的耕地面积有限之间存在的巨大差距，进一步加剧了这一结构性挑战。国际有机农业运动联盟（IFOAM-Organics International）报告称，到2024年，全球仅2.0%的耕地用于有机耕作。认证种植面积的匮乏直接限制了所需植物来源成分的供应，迫使生产者依赖高成本且不稳定的采购管道，最终延缓了新型有机药物的商业性化上市。

市场趋势

随着製造商寻求克服有机成分相对于合成成分的天然性能局限性，用于增强功能的共加工有机添加剂的兴起正在改变市场模式。为了克服基础有机淀粉中诸如压缩性和流动性差等技术难题，供应商正在加速开发共加工系统，将多种有机成分整合到单一的高性能颗粒中。这种向功能性、高附加价值有机解决方案的转变正在推动显着的商业性扩张。根据罗盖特公司于2025年3月发布的“2024财年全年业绩报告”，该公司製药解决方案部门的销售额达到8.18亿欧元，比上年增长20%，主要得益于功能性製剂形式和植物来源胶囊技术的战略增长。

同时，客製化有机辅料以提高复杂活性药物成分（API）的溶解度已成为关键趋势，这是现代药物研发管线分子复杂性日益增加的必然结果。随着药物研发转向溶解度更低、亲油性的分子，人们越来越依赖脂质载体和有机增溶剂（例如环糊精）来确保足够的生物有效性。这项技术需求在近期的製剂统计数据中也得到了印证。美国化学学会于2025年2月发布的一项研究《透过添加液态水溶助剂提高活性药物成分的溶解度》显示，约90%处于临床试验和研究阶段的新型活性药物成分水溶性较差，这凸显了开发能够稳定这些复杂製剂的先进有机辅料的迫切需求。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球有机药用辅料市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（油脂化学品、碳水化合物、石油化学品、蛋白质、其他）
  • 依功能分类（粘合剂、包衣剂、着色剂、崩坏、其他功能）
  • 依用途（口服製剂、外用製剂、注射剂、其他用途）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美有机药用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲有机药用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区有机药用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲有机药用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲有机药用辅料市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球有机药用辅料市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Organic Pharmaceutical Excipients Market is anticipated to expand from USD 10.56 Billion in 2025 to USD 16.86 Billion by 2031, achieving a CAGR of 8.11%. Organic pharmaceutical excipients are inactive ingredients obtained from certified natural origins, including plant-based starches, gums, and celluloses, which are used to create medication formulations while upholding a chemical-free profile. The primary force driving this market is a fundamental change in consumer behavior favoring preventative healthcare and a strong demand for product transparency, which urges manufacturers to substitute synthetic chemicals with natural options. This driver is supported by recent industry data; the Organic Trade Association reported that in 2024, sales of organic non-food products in the United States reached $6.2 billion, indicating a significant economic dedication to organic personal care and health solutions that directly impacts pharmaceutical sourcing decisions.

Nevertheless, market growth is hindered by the high costs and complexities involved in maintaining consistent organic supply chains. The rigorous regulations required to obtain and keep organic certification across various global regions frequently result in raw material shortages and fluctuating prices. This scarcity of compliant pharmaceutical-grade ingredients prevents manufacturers from effectively scaling production, thereby retarding the commercial introduction of new organic drug formulations.

Market Driver

The booming nutraceutical and dietary supplement industry acts as a major driver for the use of organic pharmaceutical excipients. With consumers placing greater emphasis on preventative health, there is a marked preference for clean-label products that utilize certified organic alternatives, such as plant-based celluloses, over synthetic fillers and binders. This shift compels manufacturers to match their ingredient sourcing with the natural characteristics of active components to uphold product standards and meet certification requirements. The scale of this consumer demand is highlighted by recent data; the Council for Responsible Nutrition's '2024 Consumer Survey on Dietary Supplements', released in October 2024, found that 75% of Americans use dietary supplements, emphasizing the vast market potential for organic delivery systems.

In parallel, the rising incidence of chronic diseases is boosting overall drug consumption, generating consistent demand for biocompatible excipients. Conditions with a high burden, such as diabetes and oncology, necessitate long-term treatment plans using excipients that ensure patient safety and minimize toxicity over time. According to the 'Cancer Facts & Figures 2024' published by the American Cancer Society in January 2024, new cancer cases in the U.S. were projected to surpass 2 million for the first time, indicating a critical need for expanded pharmaceutical manufacturing. This production is largely sustained by off-patent drugs, which increasingly employ organic starches for their functional stability and cost-effectiveness; the Association for Accessible Medicines noted in 2024 that generic medicines comprised 90% of all prescriptions dispensed in the U.S., representing a key volume-driven pathway for organic excipient adoption.

Market Challenge

The high operational costs and complexity associated with sustaining consistent organic supply chains represent a significant obstacle to the Global Organic Pharmaceutical Excipients Market's growth. In contrast to conventional ingredients, organic gums and starches must strictly comply with regulatory standards that differ considerably across international borders. This fragmentation in certification causes logistical delays and limits the availability of compliant pharmaceutical-grade raw materials. Consequently, manufacturers find it difficult to reach the economies of scale needed for efficient production, resulting in price instability that deters pharmaceutical companies from shifting to organic formulations.

This structural difficulty is worsened by a severe gap between the rising demand for natural ingredients and the limited global land allocated to organic farming. IFOAM - Organics International reported in 2024 that only 2.0 percent of global agricultural land was managed organically. This shortage of certified cultivation space directly restricts the supply of necessary plant-based inputs, compelling manufacturers to depend on costly and unstable sourcing networks, which ultimately delays the commercial release of new organic drug products.

Market Trends

The rise of Co-Processed Organic Excipients for Enhanced Functionality is transforming the market as manufacturers look to surmount the natural performance limitations of organic ingredients relative to synthetics. To mitigate technical issues like inadequate compressibility and flowability in basic organic starches, suppliers are increasingly developing co-processed systems that merge multiple organic components into a single high-performance particle. This move toward functional, value-added organic solutions is fueling substantial commercial expansion; Roquette's '2024 Full Year Results' from March 2025 showed that their Pharma Solutions division achieved sales of €818 million, a 20% rise from the prior year, largely supported by strategic growth in functional delivery forms and plant-based capsule technologies.

At the same time, the Customization of Organic Excipients for Solubility Enhancement in Complex APIs has become a vital trend, necessitated by the molecular intricacy of contemporary drug pipelines. As pharmaceutical research and development shifts toward more poorly soluble and lipophilic molecules, there is an increased dependence on organic solubilizers, such as lipid-based carriers and cyclodextrins, to guarantee sufficient bioavailability. This technical requirement is highlighted by recent formulation statistics; a February 2025 study titled 'Solubility Enhancement of Active Pharmaceutical Ingredients through Liquid Hydrotrope Addition' by the American Chemical Society revealed that roughly 90% of emerging active pharmaceutical ingredients in clinical trials and research demonstrate poor water solubility, creating an urgent need for advanced organic excipients capable of stabilizing these complex formulations.

Key Market Players

• Roquette Freres SA
• DuPont de Nemours Inc.
• Ashland Inc.
• BASF SE
• Kerry Group plc
• Evonik Industries AG
• Croda International plc
• The Lubrizol Corporation
• Innophos Holdings Inc.
• Wacker Chemie AG

Report Scope

In this report, the Global Organic Pharmaceutical Excipients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organic Pharmaceutical Excipients Market, By Type

• Oleochemicals
• Carbohydrates
• Petrochemicals
• Protein
• Other

Organic Pharmaceutical Excipients Market, By Function

• Binders
• Coating Agents
• Colorants
• Disintegrates
• Other Functions

Organic Pharmaceutical Excipients Market, By Application

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Applications

Organic Pharmaceutical Excipients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organic Pharmaceutical Excipients Market.

Available Customizations:

Global Organic Pharmaceutical Excipients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organic Pharmaceutical Excipients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Oleochemicals, Carbohydrates, Petrochemicals, Protein, Other)
  • 5.2.2. By Function (Binders, Coating Agents, Colorants, Disintegrates, Other Functions)
  • 5.2.3. By Application (Oral Formulations, Topical Formulations, Parenteral Formulations, Other Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Organic Pharmaceutical Excipients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Function
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organic Pharmaceutical Excipients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Function
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Organic Pharmaceutical Excipients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Function
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Organic Pharmaceutical Excipients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Function
      • 6.3.3.2.3. By Application

7. Europe Organic Pharmaceutical Excipients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Function
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organic Pharmaceutical Excipients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Function
      • 7.3.1.2.3. By Application
  • 7.3.2. France Organic Pharmaceutical Excipients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Function
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Organic Pharmaceutical Excipients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Function
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Organic Pharmaceutical Excipients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Function
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Organic Pharmaceutical Excipients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Function
      • 7.3.5.2.3. By Application

8. Asia Pacific Organic Pharmaceutical Excipients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Function
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Organic Pharmaceutical Excipients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Function
      • 8.3.1.2.3. By Application
  • 8.3.2. India Organic Pharmaceutical Excipients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Function
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Organic Pharmaceutical Excipients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Function
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Organic Pharmaceutical Excipients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Function
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Organic Pharmaceutical Excipients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Function
      • 8.3.5.2.3. By Application

9. Middle East & Africa Organic Pharmaceutical Excipients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Function
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Organic Pharmaceutical Excipients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Function
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Organic Pharmaceutical Excipients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Function
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Organic Pharmaceutical Excipients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Function
      • 9.3.3.2.3. By Application

10. South America Organic Pharmaceutical Excipients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Function
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Organic Pharmaceutical Excipients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Function
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Organic Pharmaceutical Excipients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Function
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Organic Pharmaceutical Excipients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Function
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Organic Pharmaceutical Excipients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Roquette Freres SA
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. DuPont de Nemours Inc.
• 15.3. Ashland Inc.
• 15.4. BASF SE
• 15.5. Kerry Group plc
• 15.6. Evonik Industries AG
• 15.7. Croda International plc
• 15.8. The Lubrizol Corporation
• 15.9. Innophos Holdings Inc.
• 15.10. Wacker Chemie AG

16. Strategic Recommendations

17. About Us & Disclaimer